I. McInnes
Immunology · 2003–2023
A researcher in the Science corpus: 34 papers; trusts 10 researchers and is trusted by 16 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 269 citations into it; #1,228 of 2,160 by trust here, #827 by citations
- Rheumatology — 248 citations into it; #22 of 221 by trust here, #13 by citations
- Molecular Biology — 98 citations into it
- Oncology — 79 citations into it; #237 of 1,698 by trust here, #952 by citations
- Hematology — 69 citations into it; #69 of 225 by trust here, #105 by citations
- Pathology and Forensic Medicine — 47 citations into it
- Dermatology — 28 citations into it
- Public Health, Environmental and Occupational Health — 27 citations into it
Whom I. McInnes trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Gary S. Firestein
- P. Miossec
- Georg Schett
- E. Paleolog
- N. Nishimoto
- J. Kolls
- T. Kishimoto
- S. Teitelbaum
Who trusts I. McInnes overall
- S. Gaffen
- Gary S. Firestein
- Simon A. Jones
- J. Hamilton
- Georg Schett
- M. Zeng
- I. Graham
- Massimo F. Piepoli
- E. Choy
Papers from I. McInnes's perspective
Ordered by how strongly the researchers I. McInnes trusts endorse each paper. Same corpus, a different order for every researcher.
- Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system (Nature Immunology)
- Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis (Nature Genetics)
- Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.
- TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. (Journal of Clinical Investigation)
- Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis (Science)
- IL-17 family cytokines and the expanding diversity of effector T cell lineages. (Annual Review of Immunology)
- Mechanisms of TNF-α– and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
- Targeting IL-17 and TH17 cells in chronic inflammation (Nature reviews. Drug discovery)
- Prediction of coronary heart disease using risk factor categories.
- Dickkopf-1 is a master regulator of joint remodeling (Nature Medicine)
Their papers
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (2010) — 4,103 citations
- Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. (2023) — 609 citations
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (2022) — 1,431 citations
- EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020) — 807 citations
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020) — 2,212 citations
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options (2020) — 1,251 citations
- Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. (2020) — 604 citations
- Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis (2020) — 595 citations
- Clinical applications of machine learning algorithms: beyond the black box (2019) — 413 citations
- Rheumatoid arthritis (2018) — 1,770 citations
- Pathogenetic insights from the treatment of rheumatoid arthritis. (2017) — 1,136 citations
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (2017) — 1,146 citations
- Immunopathogenesis of rheumatoid arthritis (2017) — 881 citations
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (2017) — 612 citations
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) — 1,234 citations
- European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (2015) — 893 citations
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention (2015) — 1,413 citations
- Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial. (2015) — 770 citations
- Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. (2015) — 686 citations
- Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) (2013) — 814 citations